ACTU: Actuate Therapeutics Inc Kapitalizatsiyaning daromadga nisbati

Actuate Therapeutics Inc (ACTU) brendining ramzi va logotipi

Actuate Therapeutics, Inc. (ACTU) o'z samaradorligini ma'lumotlar aniqligini ta'minlash uchun biosamplarni tashishning qat'iy nazoratiga asoslaydi. Melanoma, leykoz va oshqozon osti bezi saratoni uchun terapiyalarning ishlab chiqilishi tasdiqlash risklarini kamaytiradi, bu esa joriy sotuvlar nisbatidagi narx ko'rsatkichi bilan tasdiqlanadi; qiymati ushbu holatni aks ettiradi. Laboratoriyalarda erta bosqich tadqiqotlar validatsiyasini tezlashtirish uchun avtomatlashtirilgan manipulatorlarning joriy etilishi kompaniyaning istiqbollarini yanada yaxshilaydi.

ACTU - Actuate Therapeutics, Inc. Kapitalizatsiyaning daromadga nisbati 04.07.2022 - 16.11.2026 oraligʻida

Actuate Therapeutics, Inc (ACTU) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:ACTU - Actuate Therapeutics, Inc
Actuate Therapeutics Inc. brend mahsuloti

P/S koeffitsiyenti Actuate Therapeutics, Inc. (ACTU) kompaniyasining investitsiyaviy jozibadorligini aniqlaydi, bunda aktivning haqiqiy pul oqimlari nisbatan qimmat baholanganligini aniqlash uchun bozor kapitalizatsiyasi yillik savdo hajmi bilan solishtiriladi. P/S grafigini tahlil qilish orqali investor saratonni davolash biotexnologiyalarining no-tsiklik tabiati doirasidagi ventura xavfi darajasini baholashi mumkin, bu sohada talab tibbiy zarurat bilan belgilanadi, bu esa biznesning makroiqtisodiy zarbalarga qarshi yuqori operatsion barqarorligini ta'minlaydi.

Actuate Therapeutics, Inc. kimlar bilan raqobatlashadi

ONC - Sotuvga nisbatan narx|P/S multiplikatori HALO (Halozyme Therapeutics, Inc.)|Revolution Medicines (RVMD) - Sotuvga nisbatan narx|ascentage.com - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati CGON (cgoncology.com)|URGN: P/S multiplikatori|Bicara Therapeutics Inc (BCAX) - P/S multiplikatori|Narxning daromadga nisbati personalis.com|Kapitalizatsiyaning daromadga nisbati Erasca Corp (ERAS)|Kapitalizatsiyaning daromadga nisbati DCTH (Delcath)|Narx/daromad koeffitsiyenti Y-mAbs Therapeutics, Inc.|P/S multiplikatori AURA (Aura Biosciences Inc)|Bozor kapitallashuvining daromadga nisbati CADL|ARAY: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti sellaslifesciences.com SLS|Citius Oncology (CTOR) - Narxning daromadga nisbati|HURA - Narx/daromad koeffitsiyenti|TARA (Protara Therapeutics, Inc.) - P/S multiplikatori|P/S multiplikatori Fate Therapeutics Inc|P/S multiplikatori WHWK|P/S multiplikatori TScan Therapeutics Inc (TCRX)|Narxning daromadga nisbati championsoncology.com CSBR|XBIT - Kapitalizatsiyaning daromadga nisbati|CVM - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati OSTX (OS Therapies)|RADX: P/S multiplikatori|Artiva Biotherapeutics Inc. - Bozor kapitallashuvining daromadga nisbati|ANL (Adlai Nortye) - P/S multiplikatori|P/S multiplikatori verupharma.com|Kapitalizatsiyaning daromadga nisbati TPST (tempesttx.com)|Kapitalizatsiyaning daromadga nisbati Xilio Therapeutics Inc XLO|P/S multiplikatori RENB (Enochian BioSciences)|Mural Bio - Narxning daromadga nisbati|KAPA - Narxning daromadga nisbati|OnKure Therapeutics (OKUR) - Kapitalizatsiyaning daromadga nisbati|GDTC: P/S multiplikatori|Sotuvga nisbatan narx Curis Corp (CRIS)|APLM (apollomicsinc.com) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Tharimmune Corp (THAR)|P/S multiplikatori ADVB|GNPX - Sotuvga nisbatan narx|Narxning daromadga nisbati calidibio.com CLDI|SBFM - Kapitalizatsiyaning daromadga nisbati|XBIO - Narxning daromadga nisbati|SLRX: Narxning daromadga nisbati|Purple Biotech (PPBT) - Narxning daromadga nisbati|AON - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati BGNE|P/S multiplikatori Checkpoint Therapeutics Inc.|P/S multiplikatori ELEV|Kapitalizatsiyaning daromadga nisbati iCAD ICAD|P/S multiplikatori IKNA (Ikena Oncology, Inc.)|Bozor kapitallashuvining daromadga nisbati NTBL|Viracta Therapeutics, Inc. - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati MOR (MorphoSys Inc)|NAYA (NAYA Biosciences Inc) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Ascentage Pharma Group Ltd